Celldex Therapeutics | CLDX - Lucro Operacional





Lucro Operacional Alterar Data
AbbVie USD 6.88B 156M 2026-09
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.68B 65M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Celldex Therapeutics USD -82.25M 1.63M 2026-09
Glaxosmithkline GBP 2.13B 166M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Pfizer USD 662M 5M 2026-09
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 11.46B 1.91B 2026-06